X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11399) 11399
Newsletter (51) 51
Magazine Article (42) 42
Newspaper Article (36) 36
Transcript (22) 22
Book / eBook (13) 13
Book Chapter (3) 3
Book Review (2) 2
Publication (2) 2
Conference Proceeding (1) 1
Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10974) 10974
female (7100) 7100
index medicus (6263) 6263
oncology (5709) 5709
middle aged (4926) 4926
aged (4335) 4335
breast neoplasms - drug therapy (4163) 4163
male (4128) 4128
cancer (3631) 3631
antineoplastic agents, hormonal - therapeutic use (3416) 3416
adult (3334) 3334
breast cancer (3285) 3285
antineoplastic agents, hormonal - adverse effects (3039) 3039
chemotherapy (3014) 3014
treatment outcome (2787) 2787
care and treatment (2353) 2353
antineoplastic agents - therapeutic use (2328) 2328
antineoplastic combined chemotherapy protocols - therapeutic use (1944) 1944
antineoplastic agents - adverse effects (1916) 1916
medicine & public health (1758) 1758
aged, 80 and over (1754) 1754
breast neoplasms - pathology (1728) 1728
prostatic neoplasms - drug therapy (1697) 1697
tamoxifen (1685) 1685
therapy (1601) 1601
prostate cancer (1554) 1554
research (1442) 1442
antineoplastic combined chemotherapy protocols - adverse effects (1328) 1328
health aspects (1297) 1297
tamoxifen - adverse effects (1296) 1296
antineoplastic agents, hormonal - administration & dosage (1290) 1290
pharmacology & pharmacy (1285) 1285
tamoxifen - therapeutic use (1255) 1255
risk factors (1226) 1226
chemotherapy, adjuvant (1183) 1183
drug therapy (1180) 1180
animals (1156) 1156
postmenopausal women (1135) 1135
metastasis (1108) 1108
antineoplastic agents (1095) 1095
disease-free survival (1086) 1086
analysis (1018) 1018
women (1004) 1004
neoplasm staging (960) 960
hematology, oncology and palliative medicine (946) 946
antimitotic agents (929) 929
clinical trials (918) 918
survival (896) 896
prognosis (884) 884
carcinoma (862) 862
retrospective studies (860) 860
urology & nephrology (856) 856
drug administration schedule (841) 841
antineoplastic agents - administration & dosage (820) 820
neoplasms - drug therapy (818) 818
quality of life (778) 778
docetaxel (775) 775
follow-up studies (775) 775
prostatic neoplasms - pathology (773) 773
obstetrics & gynecology (772) 772
combined modality therapy (759) 759
neoplasm metastasis (754) 754
trial (744) 744
survival analysis (739) 739
time factors (728) 728
tumors (726) 726
breast neoplasms - mortality (717) 717
cancer therapies (700) 700
prospective studies (695) 695
breast neoplasms - metabolism (656) 656
postmenopause (651) 651
clinical trials as topic (649) 649
endocrine therapy (645) 645
dose-response relationship, drug (642) 642
radiotherapy (642) 642
breast-cancer (636) 636
androgen antagonists - therapeutic use (630) 630
estrogen (626) 626
survival rate (615) 615
randomized-trial (607) 607
antineoplastic agents - pharmacology (602) 602
cancer patients (602) 602
oncology, experimental (602) 602
randomized controlled trials as topic (601) 601
risk (596) 596
disease progression (569) 569
surgery (569) 569
aromatase inhibitors (565) 565
internal medicine (552) 552
patients (550) 550
double-blind (537) 537
antineoplastic combined chemotherapy protocols - administration & dosage (529) 529
quality-of-life (524) 524
medicine, general & internal (517) 517
pharmacology/toxicology (508) 508
androgen antagonists - adverse effects (507) 507
cancer research (504) 504
breast neoplasms - surgery (499) 499
toxicity (494) 494
prostate-specific antigen - blood (493) 493
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11091) 11091
French (131) 131
Japanese (125) 125
German (104) 104
Spanish (38) 38
Russian (29) 29
Italian (24) 24
Hungarian (13) 13
Danish (11) 11
Chinese (9) 9
Polish (9) 9
Czech (8) 8
Portuguese (8) 8
Dutch (7) 7
Bulgarian (6) 6
Norwegian (6) 6
Finnish (5) 5
Swedish (4) 4
Hebrew (3) 3
Romanian (3) 3
Serbian (3) 3
Croatian (1) 1
Korean (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Plastic and Reconstructive Surgery, ISSN 0032-1052, 01/2016, Volume 137, Issue 1, pp. 1 - 9
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2009, Volume 360, Issue 7, pp. 679 - 691
This large trial tested the effect of adding zoledronic acid to adjuvant endocrine treatment... 
BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS | MEDICINE, GENERAL & INTERNAL | BONE LOSS | SOLID TUMORS | TAMOXIFEN | METASTASES | DELTA T-CELLS | RECEPTOR | ADJUVANT THERAPY | POSTMENOPAUSAL WOMEN | AUSTRIAN BREAST | Breast Neoplasms - surgery | Triazoles - adverse effects | Follow-Up Studies | Humans | Middle Aged | Receptors, Estrogen - analysis | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Diphosphonates - therapeutic use | Adult | Female | Chemotherapy, Adjuvant | Imidazoles - therapeutic use | Drug Therapy, Combination | Goserelin - therapeutic use | Aromatase Inhibitors - therapeutic use | Diphosphonates - adverse effects | Triazoles - therapeutic use | Bone Density Conservation Agents - adverse effects | Premenopause | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Breast Neoplasms - drug therapy | Disease-Free Survival | Estrogen Antagonists - therapeutic use | Tamoxifen - therapeutic use | Estrogen Antagonists - adverse effects | Tamoxifen - adverse effects | Nitriles - adverse effects | Nitriles - therapeutic use | Zoledronic acid | Care and treatment | Usage | Breast cancer | Health aspects | Function tests (Medicine) | Chemotherapy | Acids | Womens health | Menopause | Colorectal cancer | Cytotoxicity | Radiation therapy | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10024, pp. 1163 - 1177
Journal Article
Fertility and Sterility, ISSN 0015-0282, 2010, Volume 93, Issue 1, pp. 192 - 198
Journal Article
Cochrane library, ISSN 1465-1858, 2017, Volume 2017, Issue 11, p. CD008727
Background Glucocorticoids play a major role in the treatment of acute lymphoblastic leukaemia (ALL). However, supraphysiological doses can suppress the... 
Antineoplastic Agents, Hormonal | Dexamethasone | Fluconazole | Glucocorticoids | Childhood cancers | Pituitary‐Adrenal System | Supportive care: therapy‐related side effects during treatment | Prednisone | Randomized Controlled Trials as Topic | Supportive care: side effects of cancer treatment | Adrenal Insufficiency | Blood disorders | Precursor Cell Lymphoblastic Leukemia‐Lymphoma | Hypothalamo‐Hypophyseal System | Child health | Observational Studies as Topic | Supportive care | Acute lymphoblastic leukaemia | Medicine General & Introductory Medical Sciences | Haematological malignancies | Late effects: therapy‐related side effects after treatment | Prednisolone | Cohort Studies | Cancer | GLUCAGON STIMULATION TEST | 250 MU-G | Humans | 1ST REMISSION | Antineoplastic Agents | INSUFFICIENCY | DEATH | Glucocorticoids [administration & dosage; adverse effects] | CHILDREN | MEDICINE, GENERAL & INTERNAL | Prednisolone [administration & dosage; adverse effects] | GROWTH-HORMONE | INDUCTION THERAPY | Hypothalamo-Hypophyseal System [drug effects] | ADRENOCORTICAL RECOVERY | Precursor Cell Lymphoblastic Leukemia-Lymphoma [drug therapy] | Hormonal [administration & dosage; adverse effects] | Pituitary-Adrenal System [drug effects] | Dexamethasone [administration & dosage; adverse effects] | Child | Adrenal Insufficiency [chemically induced] | CORTISOL | Hypothalamo-Hypophyseal System - drug effects | Prednisolone - adverse effects | Glucocorticoids - administration & dosage | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Prednisolone - administration & dosage | Prednisone - adverse effects | Pituitary-Adrenal System - drug effects | Antineoplastic Agents, Hormonal - administration & dosage | Fluconazole - administration & dosage | Dexamethasone - adverse effects | Fluconazole - adverse effects | Antineoplastic Agents, Hormonal - adverse effects | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Adrenal Insufficiency - chemically induced | Glucocorticoids - adverse effects
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2009, Volume 27, Issue 33, pp. 5538 - 5546
.... This trial evaluated the effect of adding lapatinib, a dual tyrosine kinase inhibitor blocking epidermal growth factor receptor and human epidermal growth factor receptor 2 (HER2... 
EFFICACY | ONCOLOGY | RANDOMIZED PHASE-II | TAMOXIFEN RESISTANCE | GROWTH | MCF-7 CELLS | COMBINATION | INHIBITOR | EXPRESSION | ESTROGEN-RECEPTOR | PLUS | Triazoles - administration & dosage | Triazoles - adverse effects | Postmenopause - drug effects | Receptors, Estrogen - metabolism | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carcinoma - mortality | Receptors, Progesterone - genetics | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Dose-Response Relationship, Drug | Nitriles - administration & dosage | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Invasiveness - pathology | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Carcinoma - pathology | Carcinoma - secondary | Carcinoma - drug therapy | Receptors, Estrogen - genetics | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Biomarkers, Tumor - analysis | Antineoplastic Agents, Hormonal - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Breast Neoplasms - drug therapy | Disease-Free Survival | Maximum Tolerated Dose | Breast Neoplasms - pathology | Quinazolines - adverse effects | Survival Analysis | Breast Neoplasms - mortality | Aged | Biomarkers, Tumor - genetics | Carcinoma - metabolism | Neoplasm Staging | Nitriles - adverse effects | Index Medicus | Carcinoma | Quinazolines | Breast Neoplasms | Life Sciences | Immunology | Triazoles | Postmenopause | Nitriles | Antineoplastic Agents, Hormonal | Tumor Markers, Biological | Receptors, Estrogen | Neoplasm Invasiveness | Antineoplastic Combined Chemotherapy Protocols | Receptor, erbB-2 | Receptors, Progesterone | Kaplan-Meiers Estimate
Journal Article